These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 33496577)

  • 1. Magnetic Bead-Based Immunoassay Allows Rapid, Inexpensive, and Quantitative Detection of Human SARS-CoV-2 Antibodies.
    Huergo LF; Selim KA; Conzentino MS; Gerhardt ECM; Santos ARS; Wagner B; Alford JT; Deobald N; Pedrosa FO; de Souza EM; Nogueira MB; Raboni SM; Souto D; Rego FGM; Zanette DL; Aoki MN; Nardin JM; Fornazari B; Morales HMP; Borges VA; Nelde A; Walz JS; Becker M; Schneiderhan-Marra N; Rothbauer U; Reis RA; Forchhammer K
    ACS Sens; 2021 Mar; 6(3):703-708. PubMed ID: 33496577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultra-fast, high throughput and inexpensive detection of SARS-CoV-2 seroconversion using Ni
    Conzentino MS; Santos TPC; Selim KA; Wagner B; Alford JT; Deobald N; Paula NM; Rego FGM; Zanette DL; Aoki MN; Nardin JM; Huergo MCC; Reis RA; Huergo LF
    Anal Biochem; 2021 Oct; 631():114360. PubMed ID: 34481802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A magnetic bead immunoassay to detect high affinity human IgG reactive to SARS-CoV-2 Spike S1 RBD produced in Escherichia coli.
    Conzentino MS; Gonçalves ACA; Paula NM; Rego FGM; Zanette DL; Aoki MN; Nardin JM; Huergo LF
    Braz J Microbiol; 2022 Sep; 53(3):1263-1269. PubMed ID: 35426068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A high-throughput Anti-SARS-CoV-2 IgG testing platform for COVID-19.
    Du J; Chu E; Zhang D; Lu CM; Zhang A; Sha MY
    J Virol Methods; 2021 Jan; 287():114009. PubMed ID: 33152411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 immunochromatographic IgM/IgG rapid test in pregnancy: A false friend?
    Fabre M; Ruiz-Martinez S; Monserrat Cantera ME; Cortizo Garrido A; Beunza Fabra Z; Peran M; Benito R; Mateo P; Paules C; Oros D
    Ann Clin Biochem; 2021 Mar; 58(2):149-152. PubMed ID: 33242972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of a multiplex flow immunoassay for detection of IgG antibodies against SARS-CoV-2 in dried blood spots.
    Turgeon CT; Sanders KA; Rinaldo P; Granger D; Hilgart H; Matern D; Theel ES
    PLoS One; 2021; 16(5):e0252621. PubMed ID: 34048503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Two Automated Immunoassays for the Detection of SARS-CoV-2 Nucleocapsid Antibodies.
    Hubbard JA; Geno KA; Khan J; Szczepiorkowski ZM; de Gijsel D; Ovalle AA; AlSalman AS; Gallagher TL; Johnston AA; Tibbetts AR; Vital SE; Cervinski MA; Nerenz RD
    J Appl Lab Med; 2021 Mar; 6(2):429-440. PubMed ID: 32976593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid response flow cytometric assay for the detection of antibody responses to SARS-CoV-2.
    Lapuente D; Maier C; Irrgang P; Hübner J; Peter AS; Hoffmann M; Ensser A; Ziegler K; Winkler TH; Birkholz T; Kremer AE; Steininger P; Korn K; Neipel F; Überla K; Tenbusch M
    Eur J Clin Microbiol Infect Dis; 2021 Apr; 40(4):751-759. PubMed ID: 33078221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-SARS-CoV-2 IgG antibody response among Indian COVID-19 patients using β-propiolactone-inactivated, whole virus-based indirect ELISA.
    Kulkarni R; Patil HP; Palkar S; Lalwani S; Mishra AC; Arankalle V
    J Virol Methods; 2021 Jan; 287():113996. PubMed ID: 33126149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptoms and immunoglobulin development in hospital staff exposed to a SARS-CoV-2 outbreak.
    Brandstetter S; Roth S; Harner S; Buntrock-Döpke H; Toncheva AA; Borchers N; Gruber R; Ambrosch A; Kabesch M
    Pediatr Allergy Immunol; 2020 Oct; 31(7):841-847. PubMed ID: 32413201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy of an automated chemiluminescent immunoassay for anti-SARS-CoV-2 IgM and IgG antibodies: an Italian experience.
    Infantino M; Grossi V; Lari B; Bambi R; Perri A; Manneschi M; Terenzi G; Liotti I; Ciotta G; Taddei C; Benucci M; Casprini P; Veneziani F; Fabbri S; Pompetti A; Manfredi M
    J Med Virol; 2020 Sep; 92(9):1671-1675. PubMed ID: 32330291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of SARS-CoV-2 antibodies with assays from Diasorin, Roche and IDvet.
    Krüttgen A; Cornelissen CG; Dreher M; Hornef MW; Imöhl M; Kleines M
    J Virol Methods; 2021 Jan; 287():113978. PubMed ID: 32979407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-step, wash-free digital immunoassay for rapid quantitative analysis of serological antibody against SARS-CoV-2 by photonic resonator absorption microscopy.
    Zhao B; Che C; Wang W; Li N; Cunningham BT
    Talanta; 2021 Apr; 225():122004. PubMed ID: 33592744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of SARS-CoV-2 Neutralizing Antibodies to an Automated Chemiluminescent Serological Immunoassay.
    Grenache DG; Ye C; Bradfute SB
    J Appl Lab Med; 2021 Mar; 6(2):491-495. PubMed ID: 33098417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 Seroprevalence in Healthcare Workers of Kaunas Hospitals during the First Wave of the COVID-19 Pandemic.
    Pereckaitė L; Dambrauskienė A; Urbonienė D; Sadauskas S; Petrikonis K; Naudžiūnas A; Vitkauskienė A
    Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33562085
    [No Abstract]   [Full Text] [Related]  

  • 16. Detection of SARS-CoV-2-specific antibodies via rapid diagnostic immunoassays in COVID-19 patients.
    Chansaenroj J; Yorsaeng R; Posuwan N; Puenpa J; Sudhinaraset N; Chirathaworn C; Poovorawan Y
    Virol J; 2021 Mar; 18(1):52. PubMed ID: 33750394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance evaluation of two SARS-CoV-2 IgG/IgM rapid tests (Covid-Presto and NG-Test) and one IgG automated immunoassay (Abbott).
    Charpentier C; Ichou H; Damond F; Bouvet E; Chaix ML; Ferré V; Delaugerre C; Mahjoub N; Larrouy L; Le Hingrat Q; Visseaux B; Mackiewicz V; Descamps D; Fidouh-Houhou N
    J Clin Virol; 2020 Nov; 132():104618. PubMed ID: 32919222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring Specific IgM and IgG Production Among Severe COVID-19 Patients Using Qualitative and Quantitative Immunodiagnostic Assays: A Retrospective Cohort Study.
    Al-Mughales JA; Al-Mughales TJ; Saadah OI
    Front Immunol; 2021; 12():705441. PubMed ID: 34539635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of 2 fully automated tests detecting antibodies against nucleocapsid N and spike S1/S2 proteins in COVID-19.
    Flinck H; Rauhio A; Luukinen B; Lehtimäki T; Haapala AM; Seiskari T; Aittoniemi J
    Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115197. PubMed ID: 32977117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Multiplex Noninvasive Salivary Antibody Assay for SARS-CoV-2 Infection and Its Application in a Population-Based Survey by Mail.
    Egorov AI; Griffin SM; Fuzawa M; Kobylanski J; Grindstaff R; Padgett W; Simmons S; Hallinger DR; Styles JN; Wickersham L; Sams E; Hudgens E; Wade TJ
    Microbiol Spectr; 2021 Oct; 9(2):e0069321. PubMed ID: 34523986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.